These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 23664118)

  • 41. Galactosyltransferase I is a gene responsible for progeroid variant of Ehlers-Danlos syndrome: molecular cloning and identification of mutations.
    Furukawa K; Okajima T
    Biochim Biophys Acta; 2002 Dec; 1573(3):377-81. PubMed ID: 12417421
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The RIN2 syndrome: a new autosomal recessive connective tissue disorder caused by deficiency of Ras and Rab interactor 2 (RIN2).
    Syx D; Malfait F; Van Laer L; Hellemans J; Hermanns-Lê T; Willaert A; Benmansour A; De Paepe A; Verloes A
    Hum Genet; 2010 Jul; 128(1):79-88. PubMed ID: 20424861
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A case of Ehlers-Danlos syndrome type VIA with a novel PLOD1 gene mutation.
    Tosun A; Kurtgoz S; Dursun S; Bozkurt G
    Pediatr Neurol; 2014 Oct; 51(4):566-9. PubMed ID: 25266621
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biosynthesis of the linkage region of glycosaminoglycans: cloning and activity of galactosyltransferase II, the sixth member of the beta 1,3-galactosyltransferase family (beta 3GalT6).
    Bai X; Zhou D; Brown JR; Crawford BE; Hennet T; Esko JD
    J Biol Chem; 2001 Dec; 276(51):48189-95. PubMed ID: 11551958
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Xylose phosphorylation functions as a molecular switch to regulate proteoglycan biosynthesis.
    Wen J; Xiao J; Rahdar M; Choudhury BP; Cui J; Taylor GS; Esko JD; Dixon JE
    Proc Natl Acad Sci U S A; 2014 Nov; 111(44):15723-8. PubMed ID: 25331875
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Spondylocheiro dysplastic form of the Ehlers-Danlos syndrome--an autosomal-recessive entity caused by mutations in the zinc transporter gene SLC39A13.
    Giunta C; Elçioglu NH; Albrecht B; Eich G; Chambaz C; Janecke AR; Yeowell H; Weis M; Eyre DR; Kraenzlin M; Steinmann B
    Am J Hum Genet; 2008 Jun; 82(6):1290-305. PubMed ID: 18513683
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency.
    Schalkwijk J; Zweers MC; Steijlen PM; Dean WB; Taylor G; van Vlijmen IM; van Haren B; Miller WL; Bristow J
    N Engl J Med; 2001 Oct; 345(16):1167-75. PubMed ID: 11642233
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues.
    Corsi A; Xu T; Chen XD; Boyde A; Liang J; Mankani M; Sommer B; Iozzo RV; Eichstetter I; Robey PG; Bianco P; Young MF
    J Bone Miner Res; 2002 Jul; 17(7):1180-9. PubMed ID: 12102052
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transcriptome analysis of skin fibroblasts with dominant negative COL3A1 mutations provides molecular insights into the etiopathology of vascular Ehlers-Danlos syndrome.
    Chiarelli N; Carini G; Zoppi N; Ritelli M; Colombi M
    PLoS One; 2018; 13(1):e0191220. PubMed ID: 29346445
    [TBL] [Abstract][Full Text] [Related]  

  • 50. B3GALT6-linkeropathy: Three illustrative patients spanning the disease spectrum.
    Coetzer KC; Dieckerhoff J; Wollnik B; Moosa S
    Eur J Med Genet; 2023 Oct; 66(10):104829. PubMed ID: 37657630
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dermatan sulfate proteoglycan and glycosaminoglycan synthesis is induced in fibroblasts by transfer to a three-dimensional extracellular environment.
    Lee PH; Trowbridge JM; Taylor KR; Morhenn VB; Gallo RL
    J Biol Chem; 2004 Nov; 279(47):48640-6. PubMed ID: 15347686
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Report of two siblings with spondylodysplastic Ehlers-Danlos syndrome and B4GALT7 deficiency.
    Lorenz D; Kress W; Zaum AK; Speer CP; Hebestreit H
    BMC Pediatr; 2021 Jun; 21(1):293. PubMed ID: 34193099
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Arterial tortuosity syndrome].
    Meyer S; Faiyaz-Ul-Haque M; Zankl M; Sailer NL; Marx N; Limbach HG; Lindinger A
    Klin Padiatr; 2005; 217(1):36-40. PubMed ID: 15640971
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extracellular matrix and platelet function in patients with musculocontractural Ehlers-Danlos syndrome caused by mutations in the CHST14 gene.
    Mendoza-Londono R; Chitayat D; Kahr WH; Hinek A; Blaser S; Dupuis L; Goh E; Badilla-Porras R; Howard A; Mittaz L; Superti-Furga A; Unger S; Nishimura G; Bonafe L
    Am J Med Genet A; 2012 Jun; 158A(6):1344-54. PubMed ID: 22581468
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Systematic investigation of the skin in Chst14-/- mice: A model for skin fragility in musculocontractural Ehlers-Danlos syndrome caused by CHST14 variants (mcEDS-CHST14).
    Hirose T; Mizumoto S; Hashimoto A; Takahashi Y; Yoshizawa T; Nitahara-Kasahara Y; Takahashi N; Nakayama J; Takehana K; Okada T; Nomura Y; Yamada S; Kosho T; Watanabe T
    Glycobiology; 2021 Feb; 31(2):137-150. PubMed ID: 32601684
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Collagen Network Formation in In Vitro Models of Musculocontractural Ehlers-Danlos Syndrome.
    Hashimoto A; Hirose T; Hashimoto K; Mizumoto S; Nitahara-Kasahara Y; Saka S; Yoshizawa T; Okada T; Yamada S; Kosho T; Watanabe T; Miyata S; Nomura Y
    Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833235
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The phenotype of the musculocontractural type of Ehlers-Danlos syndrome due to CHST14 mutations.
    Janecke AR; Li B; Boehm M; Krabichler B; Rohrbach M; Müller T; Fuchs I; Golas G; Katagiri Y; Ziegler SG; Gahl WA; Wilnai Y; Zoppi N; Geller HM; Giunta C; Slavotinek A; Steinmann B
    Am J Med Genet A; 2016 Jan; 170A(1):103-15. PubMed ID: 26373698
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Compound heterozygosity for a disease-causing G1489E [corrected] and disease-modifying G530S substitution in COL5A1 of a patient with the classical type of Ehlers-Danlos syndrome: an explanation of intrafamilial variability?
    Giunta C; Steinmann B
    Am J Med Genet; 2000 Jan; 90(1):72-9. PubMed ID: 10602121
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutations in Biosynthetic Enzymes for the Protein Linker Region of Chondroitin/Dermatan/Heparan Sulfate Cause Skeletal and Skin Dysplasias.
    Mizumoto S; Yamada S; Sugahara K
    Biomed Res Int; 2015; 2015():861752. PubMed ID: 26582078
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glycosaminoglycan alteration in the skin of children with classical Ehlers-Danlos syndrome.
    Yamakage A; Uchiyama Y; Nihei Y; Ishikawa H
    Acta Derm Venereol; 1985; 65(6):489-94. PubMed ID: 2420112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.